vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $30.5M, roughly 1.3× FGI Industries Ltd.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -8.6%, a 44.5% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -14.4%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $2.3M). Over the past eight quarters, FGI Industries Ltd.'s revenue compounded faster (-0.5% CAGR vs -15.0%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
FGI vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $39.6M |
| Net Profit | $-2.6M | $14.2M |
| Gross Margin | 26.7% | 73.1% |
| Operating Margin | -2.2% | 32.5% |
| Net Margin | -8.6% | 35.9% |
| Revenue YoY | -14.4% | -10.9% |
| Net Profit YoY | -553.1% | 117.2% |
| EPS (diluted) | $-1.63 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $39.6M | ||
| Q3 25 | $35.8M | $43.4M | ||
| Q2 25 | $31.0M | $43.4M | ||
| Q1 25 | $33.2M | $47.3M | ||
| Q4 24 | $35.6M | $44.4M | ||
| Q3 24 | $36.1M | $53.1M | ||
| Q2 24 | $29.4M | $53.1M | ||
| Q1 24 | $30.8M | $54.8M |
| Q4 25 | $-2.6M | $14.2M | ||
| Q3 25 | $-1.7M | $12.8M | ||
| Q2 25 | $-1.2M | $2.5M | ||
| Q1 25 | $-629.1K | $21.5M | ||
| Q4 24 | $-402.3K | $6.5M | ||
| Q3 24 | $-550.1K | $2.8M | ||
| Q2 24 | $163.6K | $18.5M | ||
| Q1 24 | $-412.2K | $18.8M |
| Q4 25 | 26.7% | 73.1% | ||
| Q3 25 | 26.5% | 70.6% | ||
| Q2 25 | 28.1% | 69.2% | ||
| Q1 25 | 26.8% | 79.7% | ||
| Q4 24 | 24.6% | 76.3% | ||
| Q3 24 | 25.8% | 81.5% | ||
| Q2 24 | 30.5% | 74.2% | ||
| Q1 24 | 27.4% | 72.1% |
| Q4 25 | -2.2% | 32.5% | ||
| Q3 25 | 1.0% | 36.6% | ||
| Q2 25 | -2.7% | 33.6% | ||
| Q1 25 | -3.9% | 51.1% | ||
| Q4 24 | -3.5% | 10.6% | ||
| Q3 24 | -0.2% | 26.1% | ||
| Q2 24 | -1.5% | 51.4% | ||
| Q1 24 | -1.0% | 44.6% |
| Q4 25 | -8.6% | 35.9% | ||
| Q3 25 | -4.6% | 29.6% | ||
| Q2 25 | -4.0% | 5.7% | ||
| Q1 25 | -1.9% | 45.4% | ||
| Q4 24 | -1.1% | 14.7% | ||
| Q3 24 | -1.5% | 5.3% | ||
| Q2 24 | 0.6% | 34.8% | ||
| Q1 24 | -1.3% | 34.2% |
| Q4 25 | $-1.63 | $0.15 | ||
| Q3 25 | $-0.86 | $0.12 | ||
| Q2 25 | $-0.64 | $0.02 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | $-0.38 | $0.05 | ||
| Q3 24 | $-0.29 | $0.03 | ||
| Q2 24 | $0.08 | $0.20 | ||
| Q1 24 | $-0.04 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $17.3M | $248.3M |
| Total Assets | $69.5M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $164.1M | ||
| Q3 25 | $1.9M | $127.4M | ||
| Q2 25 | $2.5M | $152.7M | ||
| Q1 25 | $1.2M | $132.1M | ||
| Q4 24 | $4.6M | $125.0M | ||
| Q3 24 | $3.0M | $137.4M | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $17.3M | $248.3M | ||
| Q3 25 | $19.7M | $248.0M | ||
| Q2 25 | $21.3M | $244.6M | ||
| Q1 25 | $21.8M | $226.4M | ||
| Q4 24 | $22.3M | $195.1M | ||
| Q3 24 | $23.5M | $205.0M | ||
| Q2 24 | $23.8M | $8.8M | ||
| Q1 24 | $23.9M | $9.0M |
| Q4 25 | $69.5M | $380.4M | ||
| Q3 25 | $73.0M | $321.4M | ||
| Q2 25 | $71.7M | $315.3M | ||
| Q1 25 | $68.5M | $284.6M | ||
| Q4 24 | $75.5M | $266.1M | ||
| Q3 24 | $74.7M | $296.5M | ||
| Q2 24 | $69.9M | $19.5M | ||
| Q1 24 | $68.6M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $52.0M |
| Free Cash FlowOCF − Capex | $2.3M | $51.2M |
| FCF MarginFCF / Revenue | 7.5% | 129.3% |
| Capex IntensityCapex / Revenue | 0.2% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $52.0M | ||
| Q3 25 | $-1.9M | $-20.9M | ||
| Q2 25 | $7.6M | $-8.3M | ||
| Q1 25 | $-7.4M | $1.9M | ||
| Q4 24 | $617.4K | $-7.3M | ||
| Q3 24 | $-915.0K | $5.0M | ||
| Q2 24 | $862.1K | $19.2M | ||
| Q1 24 | $-8.0M | $3.7M |
| Q4 25 | $2.3M | $51.2M | ||
| Q3 25 | $-2.1M | $-20.9M | ||
| Q2 25 | $7.4M | $-8.6M | ||
| Q1 25 | $-7.7M | $1.7M | ||
| Q4 24 | $-214.1K | $-7.9M | ||
| Q3 24 | $-1.1M | $4.6M | ||
| Q2 24 | $281.5K | $18.3M | ||
| Q1 24 | $-8.6M | $3.0M |
| Q4 25 | 7.5% | 129.3% | ||
| Q3 25 | -5.9% | -48.3% | ||
| Q2 25 | 23.8% | -19.9% | ||
| Q1 25 | -23.3% | 3.5% | ||
| Q4 24 | -0.6% | -17.8% | ||
| Q3 24 | -3.0% | 8.7% | ||
| Q2 24 | 1.0% | 34.5% | ||
| Q1 24 | -28.0% | 5.4% |
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.7% | 0.1% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | 2.3% | 1.3% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 2.0% | 1.6% | ||
| Q1 24 | 2.0% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | 5.27× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
